1-2 of 2
Bulent Undar
Close
Save search
Sort by
Journal Articles

Nilotinib Results in Improved Rates of Molecular Response in Turkish Newly Diagnosed CML-CP Patients: A 24-Month Update

Free
Guray Saydam, MD Prof, Ibrahim Celalettin Haznedaroglu, MD, Leylagul Kaynar, MD, Akif S. Yavuz, MD Prof, Ridvan Ali, Prof MD, Birol Guvenc, MD Prof, Olga M. Akay, MD, Zafer Baslar, Professor Doctor, Ugur Ozbek, MD PhD, Mehmet Sonmez, MD, Demet Aydin, MD, Mustafa Pehlivan, MD Assoc Prof, Bulent Undar, MD Prof, Simten Dagdas, MD Assoc Prof, Orhan M. Ayyildiz, MD Prof, Diyar Z. Akkaynak, MD, Ilkiz M. Dag, MD, Osman Ilhan, MD
Journal: Blood
Blood (2014) 124 (21): 5532.
https://doi.org/10.1182/blood.V124.21.5532.5532
Published: 2014
Journal Articles

Use Of Nilotinib As a First Line Treatment In Adult Patients With Philadelphia Chromosome-Positive and Chronic Phase Myeloid Leukemia

Free
Guray Saydam, MD, Prof, Ibrahim C. Haznedaroglu, MD, Prof, Leylagul Kaynar, MD, Prof, Akif S. Yavuz, MD, Prof, Ridvan Ali, MD, Prof, Birol Guvenc, MD, Prof, Olga M. Akay, MD, Zafer Baslar, Professor Doctor, Ugur Ozbek, MD, Prof, Mehmet Sonmez, M.D., Demet Aydin, MD, Mustafa Pehlivan, MD, Assoc Prof, Bulent Undar, MD, Prof, Simten Dagdas, MD, Assoc Prof, Orhan M. Ayyildiz, MD, Prof, Diyar Z. Akkaynak, MD, Ilkiz M. Dag, MD, Osman Ilhan, MD, Prof
Journal: Blood
Blood (2013) 122 (21): 2742.
https://doi.org/10.1182/blood.V122.21.2742.2742
Published: 2013